Dr. Robert Jones

Anesthesiology
Office
4242 Medical Dr Ste 1300, 
San Antonio, TX 
Office
4242 Medical Dr Ste 1300, 
San Antonio, TX 

Overview

Robert Jones is an Anesthesiologist practicing medicine in San Antonio, Texas.

His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Febrile Neutropenia, Orchiectomy, and Hepatectomy.

He is actively involved in clinical research, co-authoring 192 peer reviewed articles and participating in 11 clinical trials.

Specialties

Anesthesiology

Licenses

Anesthesiology in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
4242 Medical Dr Ste 1300, San Antonio, TX 78229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
Enrollment Status: Terminated
Publish Date: April 14, 2026
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Bevacizumab, Pembrolizumab, Carboplatin
Study Phase: Phase 1/Phase 2
A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor
A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor
Enrollment Status: Active_not_recruiting
Publish Date: November 26, 2025
Intervention Type: Drug
Study Drugs: AZD5363, Fulvestrant
Study Phase: Phase 1/Phase 2
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug, Other
Study Drug: 177Lu-PSMA-617
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
Enrollment Status: Terminated
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drug: Trilaciclib
Study Phase: Phase 3
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drugs: GSK525762, Abiraterone, Enzalutamide, Prednisone
Study Phase: Phase 1
[F-18] Fluciclovine (Axumin) PET/CT vs. [F-18] NaF PET/CT in the Evaluation of Prostate Cancer Osseous Metastatic Disease
[F-18] Fluciclovine (Axumin) PET/CT vs. [F-18] NaF PET/CT in the Evaluation of Prostate Cancer Osseous Metastatic Disease
Enrollment Status: Withdrawn
Publish Date: April 01, 2022
Intervention Type: Device
Study Phase: Not Applicable
Adaptive Study of the Safety, Tolerability & Efficacy of Autologous γδ T Lymphocyte Therapy (ImmuniCell®) in Patients With Advanced Cancers Refractory to Current Treatment or Have Indolent Disease for Which Immunotherapy May be Beneficial
Adaptive Study of the Safety, Tolerability & Efficacy of Autologous γδ T Lymphocyte Therapy (ImmuniCell®) in Patients With Advanced Cancers Refractory to Current Treatment or Have Indolent Disease for Which Immunotherapy May be Beneficial
Enrollment Status: Terminated
Publish Date: March 10, 2022
Intervention Type: Biological
Study Phase: Phase 2
First-in-human, Dose-escalating Safety Study of Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax® TF ADC) in Patients With Locally Advanced and/or Metastatic Solid Tumors Known to Express Tissue Factor
First-in-human, Dose-escalating Safety Study of Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax® TF ADC) in Patients With Locally Advanced and/or Metastatic Solid Tumors Known to Express Tissue Factor
Enrollment Status: Completed
Publish Date: December 29, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Multi-center, Open-label Trial Investigating the Efficacy and Safety of Continued Treatment With Tisotumab Vedotin in Patients With Solid Tumors Known to Express Tissue Factor.
A Multi-center, Open-label Trial Investigating the Efficacy and Safety of Continued Treatment With Tisotumab Vedotin in Patients With Solid Tumors Known to Express Tissue Factor.
Enrollment Status: Completed
Publish Date: November 04, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

191 Total Publications

The modular nature of long-association pathways in the human brain.
The modular nature of long-association pathways in the human brain.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Brandon Bregman
Anesthesiology
Expertise in
1
conditions
Dr. Brandon Bregman
Anesthesiology

Northwest Anesthesiology SA P.A.

45 NE Loop 410 Ste 900, 
San Antonio, TX 
 (5.1 miles away)
210-413-2932
Languages Spoken:
English
See accepted insurances

Brandon Bregman is an Anesthesiologist practicing medicine in San Antonio, Texas. Dr. Bregman is highly rated in 1 condition, according to our data. His clinical expertise encompasses Ptosis.

Expertise in
4
conditions
Dr. Jerome J. Aul
Anesthesiology
Expertise in
4
conditions
Dr. Jerome J. Aul
Anesthesiology

Emergenchealth PLLC

11212 State Hwy 151, 
San Antonio, TX 
 (8.4 miles away)
210-703-8801
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jerome Aul is an Anesthesiologist practicing medicine in San Antonio, Texas. Dr. Aul is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Sacroiliac Joint Disease, Phantom Limb Pain, Fractured Spine, Opioid Induced Constipation, and Ureteroscopy. Dr. Aul is currently accepting new patients.

Expertise in
3
conditions
Dr. Liliana Meskill
Anesthesiology
Expertise in
3
conditions
Dr. Liliana Meskill
Anesthesiology

Office

5364 Fredericksburg Rd Ste 100, 
San Antonio, TX 
 (0.8 miles away)
210-441-4330
Languages Spoken:
English
See accepted insurances

Liliana Meskill is an Anesthesiologist practicing medicine in San Antonio, Texas. Dr. Meskill is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Chronic Pain, Sacroiliac Joint Disease, Herniated Disk, and Cervical Spondylosis.

Frequently Asked Questions about Dr. Robert Jones

How do I make an appointment with Dr. Robert Jones?

You can book an appointment with Dr. Robert Jones by calling their office at 210-615-1187. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert Jones a top-rated expert for Orchiectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert Jones is classified as an Experienced expert for Orchiectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert Jones specialize in?

While Dr. Robert Jones is a Anesthesiology, they have specific expertise in Orchiectomy, Hepatectomy, and Nephrectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Anesthesiology.

Does Dr. Robert Jones participate in research or clinical trials?

Yes. Dr. Robert Jones has published 191 articles and abstracts on conditions like Orchiectomy. You can view a list of Dr. Robert Jones's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jones's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile